ICPT - Intercept Pharma Q2 2023 Earnings Preview

2023-08-01 11:17:37 ET

• Intercept Pharma ( NASDAQ: ICPT ) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, before market open.
• The consensus EPS Estimate is -$0.46 (+32.4% Y/Y) and the consensus Revenue Estimate is $79.57M (+10.9% Y/Y).
• Over the last 2 years, ICPT has beaten EPS estimates 38% of the time and has beaten revenue estimates 63% of the time.
• Over the last 3 months, EPS estimates have seen 5 upward revisions and 1 downward. Revenue estimates have seen 3 upward revisions and 3 downward.

For further details see: